Clinical course and prognosis of patients with lung cancer who develop anticancer therapy-related pneumonitis.

Taichi MatsubaraMasafumi YamaguchiMikako JinnouchiShinkichi TakamoriTakatoshi FujishitaRyo ToyozawaKensaku ItoMototsugu ShimokawaTakashi SetoTatsuro Okamoto

Published in: Journal of cancer research and clinical oncology (2021)

Although patients who developed pneumonitis had relatively short survival times, the interval between initial therapy and pneumonitis had survival impact. Survival can be prolonged by administering further cancer treatment after resolution of pneumonitis.

Keyphrases

interstitial lung disease
free survival
stem cells
single molecule
bone marrow
drug induced